))
7.4 million Americans could gain Medicare or Medicaid coverage for anti-obesity drugs under Biden proposal
Manage episode 453571222 series 3609475
Innhold levert av Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S.. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Esther C Kane CAPS, C.D.S., Esther C Kane CAPS, and C.D.S. eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Summary of article found on WREX.com:
The Biden administration proposed expanding Medicare and Medicaid coverage for costly anti-obesity drugs, potentially benefiting millions of seniors and low-income individuals. This could significantly reduce out-of-pocket expenses, but the proposal lacks details and faces uncertainty under the incoming Trump administration, with differing opinions from key appointees.
Currently, limited access due to high drug costs restricts widespread use, and the financial implications for Medicare are substantial, with estimates reaching billions of dollars annually. While some private insurers are covering these medications, state Medicaid programs show varied levels of coverage, highlighting the cost concerns and potential challenges in broader implementation.
12 episoder
Del
